Fortress biotech inc

Major-Pharmaceuticals

FBIOP


2 Gansevoort Street
New York , NY 10014

Executive/
Director

Links

Price

  • Last Close
  • $ 6.98
    $ +0.11 1.6 %
    Jan 3, 2025
  • 52-Week High/Low
  • $17.84 - $5.97
  • YTD
  • 11.3%

  • Trading Volume
  • 2
  • Market Cap Full
  • $ 575.7M
  • Shares Outstanding
  • 82.5M
    May 7, 2020
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 4.6% 36.6% -5% 22.7% -7.4% 3.6% 37.6% 11.3%
Q2 - - -5.4% 7.7% 4% 9% -23.9% -4.2% -3.8% -
Q3 - - -9.2% -3.4% 8% -0.1% 0.9% -33.7% -21.8% -
Q4 - -6.2% -20% 0.9% 3.7% -0.2% -4.2% 3.3% 7% -
J F M A M J J A S O N D
2025 11.3% - - - - - - - - - - -
2024 10.9% 14.5% 8.4% -9.8% -1.3% -1.3% -46% -21.8% - - - 10%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-29%43%-6%33%-32%-31%-48%11%

Earnings

2016 2017 2018 2019 2020 2021 2022
Q1 - - - - - - -
Q2 - - - - -0.19 - -
Q3 - - - - - - -
Q4 - - - - - - -
A 0 0 0 0 -0.2 -0.8 -1

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2020 2021
Q1 0.58594 0.19531
Q2 0.58594 0.19531
Q3 0.19531 0.19531
Q4 0.19531 0.19531
A 1.5625 0.78124
2018 2019 2020
Mar - 61.3 78.5
Jun 52.9 65.2 82.5
Sep 54.3 69 -
Dec 56.7 70.8 -

Financial Ratios

20222021202020192018
Valuation
Dividends per share 1 2.3 2.3 2.3 2.3